CRP and interstitial lung disease: C-reactive protein (CRP), a homopentameric acute-phase reactant protein and part of the innate immune response to systemic inflammation, was found to be a predictive biomarker of disease severity and survival of ILD and identifying patients requiring intensive therapy [14].